Add like
Add dislike
Add to saved papers

How does exercise, with and without diet, improve pain and function in knee osteoarthritis? A secondary analysis of a randomised controlled trial exploring potential mediators of effects.

OBJECTIVE: Explore mediators of effects of two 6-month telehealth-delivered exercise programs, with and without weight loss diet, on pain and function improvements in knee osteoarthritis.

METHODS: Secondary analysis of 345 participants from a three-arm randomised controlled trial of exercise (Exercise) and exercise plus diet (Diet+Exercise) versus information (Control). Outcomes were changes in pain (11-point Numeric Rating Scale) and function (WOMAC, 0-68) at 12-months. Potential mediators were change at 6 months in i) attitudes towards self-management, ii) fear of movement, iii) arthritis self-efficacy, iv) weight, v) physical activity, and vi) willingness for knee surgery. For Diet+Exercise vs Exercise, only change in weight was evaluated.

RESULTS: Possible mediators of Exercise vs Control included reduced fear of movement (accounting for -1.11 [95% confidence interval: -2.15, -0.07] units improvement in function) and increased arthritis self-efficacy (-0.40 [-0.75, -0.06] reduction in pain, -1.66 [-3.04, -0.28] improvement in function). Diet+Exercise vs Control mediators included reduced fear of movement (-1.13 [-2.17, -0.08] improvement in function), increased arthritis self-efficacy (-0.77 [-1.26, -0.28] reduction in pain, -5.15 [-7.34, -2.96] improvement in function), and weight loss (-1.20 [-1.73, -0.68] reduction in pain, -5.79 [-7.96, -3.63] improvement in function). Weight loss mediated Diet+Exercise vs Exercise (-0.89 [-1.31, -0.47] reduction in pain, -4.02 [-5.77, -2.26] improvement in function).

CONCLUSION: Increased arthritis self-efficacy, reduced fear of movement, and weight loss may partially mediate telehealth-delivered exercise program effects, with and without diet, on pain and/or function in knee osteoarthritis. Weight loss may partially mediate the effect of diet plus exercise, compared to exercise alone. This article is protected by copyright. All rights reserved.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app